Given the huge number of presentations and speakers, we recommend you to download the brochure below.
André Choulika, Chairman & Chief Executive Officer, Cellectis
Andrea Piccin, Consultant Haematologist, Haematology Dept & BMT Unit, San Maurizio Regional Hospital Bolzano
Chaim Lebovits, CEO, Brainstorm Cell Therapeutics
Christoph Neyer, Director Business Development, InGeneron GmbH
Claudia Mitchell, CEO, Universal Cells, Inc.
Gerry Graham, Head, Chemokine Research Group & Deputy Head of the Institute of Infection, Immunity and Inflammation, University of Glasgow
Giovanna Lombardi, Professor, Human Transplant Immunology, Transplantation Immunology & Mucosal Biology, MRC Centre for Transplantation, King’s College London (KCL)
James Miskin, Chief Technical Officer, Oxford BioMedica
Jane Lebkowski, President of R&D, Asterias Biotherapeutics
John Campbell, Associate Director, Research, Development & Innovation, SNBTS, National Science Laboratory
Katy Spink, Chief Operating Officer, Asterias Biotherapeutics
Kristin Comella, Chief Science Officer, US Stem Cell Inc.
Marc Turner, Medical Director, SNBTS
Margo Roberts, CSO, Kite Pharma
Norio Nakatsuji, Founding Director, Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University
Pascale V Guillot, Head of the Cellular Reprogramming & Perinatal Therapy Team, Institute for Women’s Health UCL
Paul Peter Tak, Professor of Medicine, Rheumatology, Academic Medical Center, University of Amsterdam AMC; Senior Vice President of Research and Development Pipeline and Chief Immunology Officer, GSK; Board Member, Galvani
Peder Olofsson, Leader, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet
Roger Smith, Professor, Equine Orthopaedics, Royal Veterinary College (RVC)
Stephen Badylak, Professor, Department of Surgery, Deputy Director, McGowan Institute for Regenerative Medicine (MIRM); Director, Center for Pre-Clinical Tissue Engineering within the Institute
Václav Procházka, Deputy Director for Science & Research, University Hospital Ostrava
16–18 May 2018, London, UK